Highlighting Advances in Transplant Monitoring and Allograft Injury Detection at ISHLT 2026 – Natera
Natera shared a post on LinkedIn: “During our symposium at this year’s ISHLT – International Society for Heart and Lung Transplantation annual meeting, we highlighted how donor-derived cell-free DNA…
Read the full articleYou might also wanna read
Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy
Methylation-based ctDNA monitoring in 57 patients closely reflects outcomes in ER+, HER2- metastatic breast cancer during CDK4/6 inhibitor t
Timing of ctDNA Testing in HR+/HER2- Advanced Breast Cancer
Conditions : Advanced Breast Cancer Sponsors : Geneplus-Beijing Co. Ltd. Recruiting
Multi-omics biomarkers in lung fluid predict chronic lung allograft dysfunction after transplantation
In a multi-omics analysis of lung fluid samples from patients who underwent lung transplantation, Giulia Iacono and colleagues explore molec
plos.io·15d ago
Natera, Germany’s Pirche Partner on Testing for Kidney Transplant Risk and Monitoring
The collaboration aims to connect Pirche's TxPredictor risk stratification platform with Natera's Prospera monitoring test.
Redirecting
Here is the link to our new research article that was just published in Cell Reports Medicine ( Us…
Illumina Doubles Down on Newborn Sequencing: Ion Genomics Newsletter, June 23, 2026
10x teams up with Cleveland Clinic, Norway embraces nanopore-based brain cancer dx, Guardant-TwinStrand legal update, a World Cup-related co
Comments
Sign in to join the conversation.
No comments yet. Be the first.